Ledger.Open graph →
SEC Form D · filed May 27, 2015

NeuroVive Pharmaceutical AB

Offering
$25.0M
Sold
$7.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
81 LUND, V7
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Jan Nilsson · Sunnyvale, CAExecHelmuth M. Von Moltke · 81 Lund, V7DirectorHelena M. Levander · 81 Lund, V7DirectorCatharina Johansson · 81 Lund, V7ExecArne M. Ferstad · 81 Lund, V7DirectorMarcus M. Keep · 81 Lund, V7DirectorCarl F. Olsson · 81 Lund, V7DirectorMikael Bronnegard · 81 Lund, V7ExecBoel M. Flodgren · 81 Lund, V7DirectorAnna M. Bernsten · 81 Lund, V7DirectorEskil Elmer · 81 Lund, V7ExecGregory Batcheller · 81 Lund, V7Exec · DirectorJan Nilsson · 81 Lund, V7ExecHelmuth M. Von Moltke · 81 Lund, V7DirectorHelena M. Levander · 81 Lund, V7DirectorCatharina Johansson · 81 Lund, V7ExecArne M. Ferstad · 81 Lund, V7DirectorMarcus M. Keep · 81 Lund, V7DirectorCarl F. Olsson · 81 Lund, V7DirectorMikael Bronnegard · 81 Lund, V7ExecBoel M. Flodgren · 81 Lund, V7DirectorAnna M. Bernsten · 81 Lund, V7DirectorEskil Elmer · 81 Lund, V7ExecGregory Batcheller · 81 Lund, V7Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗